The synthesis of 2-benzazocines using ring-closing metathesis as a key step

Tetrahedron

Volumn 63, Issue 22, 2007, Pages 4737-4747

  Panayides, Jenny Lee ^a   Pathak, Rakhi ^a   Panagiotopoulos, Helen ^a   Davids, Hajierah ^a   Fernandes, Manuel A ^a   de Koning, Charles B ^a   van Otterlo, Willem A L ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

1 [7 ISOPROPOXY 8 METHOXY 3,6 DIHYDRO 2 BENZAZOCIN 2(1H) YL] 1 ETHANONE; 2 (BENZYLSULFONYL) 7 ISOPROPOXY 8 METHOXY 1,2,3,4,5,6 HEXAHYDRO 2 BENZAZOCINE; 2 (BENZYLSULFONYL) 7 ISOPROPOXY 8 METHOXY 1,2,3,6 TETRAHYDRO 2 BENZAZOCINE; 2 ALLYL 3 ISOPROPOXY 4 METHOXYBENZALDEHYDE; 5 ISOPROPOXY 4 METHOXY 2 (3 PHENYL 2 PROPENYL)BENZALDEHYDE; 7 ISOPROPOXY 8 METHOXY 2 [(4 METHYLPHENYL)SULFONYL] 1,2,3,6 TETRAHYDRO 2 BENZAZOCINE; BENZALDEHYDE DERIVATIVE; BENZAZOCINE DERIVATIVE; COLCHICINE; TERT BUTYL 7 ISOPROPOXY 8 METHOXY 3,6 DIHYDRO 2 BENZAZOCINE 2(1H) CARBOXYLATE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CLAISEN REARRANGEMENT; COPE REARRANGEMENT; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RING CLOSING METATHESIS;

EID: 34247529894     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2007.03.087     Document Type: Article

References (36)

1. Horton D.A., Bourne G.T., and Smythe M.L. Chem. Rev. 103 (2003) 893-930
2. Qadir M., Cobb J., Sheldrake P.W., Whittall N., White A.J.P., Hii K.K., Horton P.N., and Hursthouse M.B. J. Org. Chem. 70 (2005) 1545-1551
3. Qadir M., Cobb J., Sheldrake P.W., Whittall N., White A.J.P., Hii K.K., Horton P.N., and Hursthouse M.B. J. Org. Chem. 70 (2005) 1552-1557
4. Grunewald G.L., Dahanukar V.H., Ching P., and Criscione K.R. J. Med. Chem. 39 (1996) 3539-3546
5. Sato S., Tanioka A., Ikeda M., and Izawa S. Bioorg. Med. Chem. 13 (2005) 5717-5732
6. Sato S., Tanioka A., Ikeda M., and Izawa S. Bioorg. Med. Chem. Lett. 15 (2005) 1479-1484
7. Sato S. Tetrahedron Lett. 45 (2004) 8475-8478
8. Viladomat F., Bastida J., Codina C., Campbell W.E., and Mathee S. Phytochemistry 40 (1995) 307-311
9. Bergemann S., Brecht R., Büttner F., Guénard D., Gust R., Seitz G., Stubbs M.T., and Thoret S. Bioorg. Med. Chem. 11 (2003) 1269-1281
10. Brecht R., Seitz G., Guénard D., and Thoret S. Bioorg. Med. Chem. 8 (2000) 557-562
11. See the following reviews and other reviews cited therein:
12. Schmidt B., and Hermanns J. Curr. Org. Chem. 10 (2006) 1363-1396
13. McReynolds M.D., Dougherty J.M., and Hanson P.R. Chem. Rev. 104 (2004) 2239-2258
14. Deiters A., and Martin S.F. Chem. Rev. 104 (2004) 2199-2238
15. For the synthesis of benzo-fused compounds by RCM from our group, see the following recent examples and references cited therein:
16. Pathak R., Panayides J.-L., Jeftic T.D., de Koning C.B., and van Otterlo W.A.L. S. Afr. J. Chem. 60 (2007) 1-7. http://blues.sabinet.co.za/sajchem/ (http://blues.sabinet.co.za/sajchem/)
17. Coyanis E.M., Panayides J.-L., Fernandes M.A., de Koning C.B., and van Otterlo W.A.L. J. Organomet. Chem. 691 (2006) 5222-5239
18. van Otterlo W.A.L., Ngidi E.L., Kuzvidza S., Morgans G.L., Moleele S.S., and de Koning C.B. Tetrahedron 61 (2005) 9996-10006
19. van Otterlo W.A.L., Morgans G.L., Madeley L.G., Kuzvidza S., Moleele S.S., Thornton N., and de Koning C.B. Tetrahedron 61 (2005) 7746-7755
20. van Otterlo W.A.L., Coyanis E.M., Panayides J.-L., de Koning C.B., and Fernandes M.A. Synlett (2005) 501-505
21. van Otterlo W.A.L., Ngidi E.L., de Koning C.B., and Fernandes M.A. Tetrahedron Lett. 45 (2004) 659-662
22. van Otterlo W.A.L., Pathak R., and de Koning C.B. Synlett (2003) 1859-1861
23. van Otterlo W.A.L., Ngidi E.L., Coyanis E.M., and de Koning C.B. Tetrahedron Lett. 44 (2003) 311-313
24. Lane C., and Snieckus V. Synlett (2000) 1294-1296
25. de Koning C.B., Michael J.P., and Rousseau A.L. J. Chem. Soc., Perkin Trans. 1 (2000) 787-797
26. Synthetic work done by Ms J.-L. Panayides (MSc), and Ms R. Pathak (PhD) and biological testing by Ms H. Panagiotopoulos (MSc).
27. 2=0.1287. CCDC-626420 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge at www.ccdc.cam.ac.uk/conts/retrieving.html [or from the Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax (internat.): +44 1223/336-033; E-mail: deposit@ccdc.cam.ac.uk].
28. 2=0.1332. CCDC-626421 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge at www.ccdc.cam.ac.uk/conts/retrieving.html [or from the Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax (internat.): +44 1223/336-033; E-mail: deposit@ccdc.cam.ac.uk].
29. Huang K.-S., Wang E.-C., and Chen H.-M. J. Chin. Chem. Soc. 51 (2004) 585-605
30. For other papers commenting on the possibility of steric buttressing effects by ortho-groups in (i) RCM see:
31. Evans P., Grigg R., and York M. Tetrahedron Lett. 41 (2000) 3967-3970
32. Evans P., Grigg R., and Monteith M. Tetrahedron Lett. 40 (1999) 5247-5250 (ii) For Pauson-Khand reactions see:
33. Lovely C.J., Seshadri H., Wayland B.R., and Cordes A.W. Org. Lett. 3 (2001) 2607-2610
34. 1H NMR spectrum, so that no coupling constants could be determined.
35. Mosmann T. J. Immunol. Methods 65 (1983) 55-63
36. Perrin D.D., and Armarego W.L.F. Purification of Laboratory Chemicals (1988), Pergamon, London